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Introduction
Chronic obstructive pulmonary disease (COPD) 
is a serious global health problem, which is increas-
ing in prevalence worldwide, with serious social 
and economic burdens [GOLD, 2011]. The 
World Health Organization (WHO) estimates 
that around 210 million people worldwide have 
COPD [WHO, 2008]. COPD is the primary con-
tributor to mortality caused by chronic lower res-
piratory diseases, which became the third leading 
cause of death in the USA in 2008 [CDC, 2012]. 
A chronic inflammatory response to inhaled 
smoke and other noxious particles results in path-
ological changes in susceptible subjects with sub-
sequent air trapping, progressive airflow limitation 
and increasing breathlessness characteristic of 
COPD. A diminished ratio of forced expiratory 
volume in 1 s to forced vital capacity (FEV1/FVC) 
has frequently been used in clinical practice and 
research to diagnose COPD, with severity based 
on the level of FEV1. This can, however, lead to 
confusion and it is now recommended that the 
term ‘COPD’ only be used in the appropriate 
clinical (diagnostic) context [Agusti and Vestbo, 
2011; GOLD, 2011; Postma et al. 2012].
Until recently, cigarette smoking was considered 
the main causal factor for developing COPD. 
However, evidence from population-based stud-
ies now suggests that both indoor and outdoor 
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pollution and gene–environment interactions 
make a greater contribution to the burden of 
COPD than previously appreciated [Salvi and 
Barnes, 2009]. In addition, there has been grow-
ing awareness that the origins of many chronic 
adult lung diseases such as COPD may arise very 
early in life, that is, the ‘foetal origins’ hypothesis. 
The concept that chronic respiratory disease in 
adulthood is not simply due to an accelerated 
decline in lung function with ageing, but failure to 
achieve optimal peak function by early adulthood 
due to prior adverse exposures, was first proposed 
several decades ago. Subsequent studies showed 
that both low birth weight (LBW) and respiratory 
infections in infancy were associated with 
decreased adult lung function and death from 
COPD [Barker et al. 1991]. Evidence to support 
the concept of ‘foetal programming’, whereby 
insults during critical periods of development 
produce permanent structural, physiological or 
epigenetic changes with lifelong consequences 
[Miller and Marty, 2010; Barker, 2012], has also 
been provided by experimental animal models 
[Kallapur and Ikegami, 2006; Kramer et al. 2009; 
Shimoda and Semenza, 2011; Abbott and Winzer-
Serhan, 2012; Hilgendorff et al. 2012; Magnani 
et al. 2012; Maritz and Mutemwa, 2012; 
Sutherland et al. 2012]. These studies have shown 
that insults to the developing lung during intrau-
terine or very early postnatal life lead to increased 
susceptibility to respiratory disease during both 
childhood and later life [Gluckman et al. 2008; 
Harding and Maritz, 2012].
Recent adaptations that enable spirometric meas-
ures of lung function to be applied from birth and 
throughout the preschool years [Stocks and Lum, 
2012], and the incorporation of such tests into 
clinical and epidemiological studies commencing 
from birth have greatly enriched our understand-
ing of the effects of prenatal insults and the early 
origins of adult lung disease. Subsequent follow up 
of these cohorts into adult life has also produced 
clear evidence of ‘tracking’, whereby an individu-
al’s lung function remains on a similar centile over 
time. Thus, infants born with low lung function 
due to prenatal insults or those in whom normal 
lung and airway growth during the first years of life 
is impeded by postnatal insults, tend to retain this 
position thereafter [Bisgaard et al. 2012]. Since 
diminished lung function by early school age is a 
strong predictor of subsequent low lung function 
in early adulthood [Phelan et al. 2002; Sears et al. 
2003; Stern et al. 2007], such individuals will be at 
increased risk of COPD [James et al. 2005].
This review will focus on factors that affect struc-
tural and functional maturation of the lung and 
the impact of alterations in early lung develop-
ment (i.e. up to 5 years of age) on COPD. Due to 
the immense literature in this field, citations dur-
ing the past decade have been prioritized, the bib-
liographies of which contain pertinent references 
to the older literature. Since the ultimate result of 
aberrant lung development depends on the type, 
severity and duration of the insult and the devel-
opmental stage at which it occurs [Kallapur and 
Ikegami, 2006], the review commences with a 
brief description of normal lung development.
Normal lung development
Lung development, which is influenced by numer-
ous mechanical and biochemical factors, com-
mences in utero and continues through various 
phases to adolescence and early adulthood 
[Quanjer et al. 2010, 2012], with the most marked 
structural changes occurring during foetal life 
and the first few years after birth [Burri, 2006]. In 
humans, the lung first appears during the fourth 
week of gestation and the two lungs can be distin-
guished as separate organs by 6 weeks. By 17 
weeks’ gestation, all conducting airways have 
formed by branching morphogenesis [Morrisey 
and Hogan, 2010], with airway wall structure and 
epithelium being essentially in adult form by 24 
weeks’ gestation. Mechanical forces, exerted on 
lung tissue through alterations in lung expansion, 
are a major determinant of foetal lung develop-
ment [Hooper and Wallace, 2006]. Such forces 
are dependent on appropriate quantities of lung 
fluid and foetal breathing movements, which are 
detected from about 10 weeks’ gestation. Airway 
smooth muscle (present from 6 weeks’ gestation 
and innervated from 8 weeks’ gestation) is impor-
tant for fluid movement within the lung. From 16 
weeks’ to 27 weeks’ gestation there is growth and 
maturation of the peripheral airways to form pro-
spective respiratory airways, differentiation of epi-
thelial cells to form type I and type II alveolar 
cells and further development of the pulmonary 
capillary network. By this stage, the blood–gas 
barrier is as thin as in the adult and of sufficient 
surface area to sustain life. Alveoli appear from 29 
weeks’ gestation by a process of alveologenesis 
[Galambos and Demello, 2008], which depends 
on the presence of elastin, smooth muscle cells 
and a capillary network [Burri, 2006], with 100–
150 million alveoli present by 40 weeks’ gestation, 
that is, ‘full-term’ [Stocks and Hislop, 2002]. 
While some structural studies have suggested that 
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the variable adult number of alveoli (300–600 
million) is reached by 2–4 years, there is no cer-
tainty about when alveoli finally cease to multiply. 
Recent studies using helium3 magnetic resonance 
imaging in man [Butler et al. 2012; Narayanan 
et al. 2012], as well as experimental animal studies 
[Schittny et al. 2008], suggest that alveoli may 
continue to increase in number as well as in size 
and complexity through to adolescence and even 
adulthood. While this offers exciting possibilities 
with respect to recovery from earlier injuries, it also 
widens the potential window of vulnerability of the 
developing lung, with respect to environmental 
exposures [ATS, 2004]. Alveoli continue to increase 
in size and complexity to increase the gas-exchang-
ing surface area until body growth is complete.
After birth, lung size increases with body size, but 
is also influenced by age, sex and ethnicity [Quanjer 
et al. 2010, 2012]. Maximum lung volumes are 
attained at around 22 years in males and slightly 
earlier in females [Kohansal et al. 2009; Quanjer 
et al. 2012], representing a 30-fold increase in lung 
volume and a 20-fold increase in gas-exchanging 
surface area between birth and maturity, with at 
least a doubling of airway length and diameter over 
the same period. Even in health, both FEV1 and 
FVC gradually decline after reaching their peak in 
early adulthood, due to a gradual loss of lung elas-
ticity [Quanjer et al. 2012]. Changes in FEV1/FVC 
occur with age, being highest in early childhood 
when the airways are relatively large in relation to 
lung volume and elastic lung recoil is high [Quanjer 
et al. 2010]. Consequently, the use of fixed thresh-
olds, such as < 0.7 for FEV1/FVC, to diagnose air-
way obstruction should be avoided as it results in 
serious underdiagnosis in younger subjects and 
overdiagnosis in the elderly [Quanjer et al. 2011, 
2012; Brusasco, 2012].
Early life influences that may predispose  
to COPD
The extent to which insults to the developing lung 
are associated with subsequent increased risk of 
COPD depends on the underlying cause, timing 
and severity of such derangements. For clarity, 
various risk factors are discussed individually 
below, but in reality it is the interaction between 
such factors in genetically susceptible individuals 
that will be important in predisposing to COPD. 
Whereas prenatal factors are more likely to impair 
airway development, postnatal factors tend to 
impact on subsequent airway growth, as well as 
alveolarization and microvasculature. Diminished 
airway calibre associated with suboptimal intrau-
terine conditions may be evident shortly after 
birth and prior to any postnatal insults. Reduced 
airway calibre and hence airflow limitation may 
reflect structural changes to the airway wall and 
supporting parenchyma as well as bronchial hyper-
responsiveness (BHR). The complex relationship 
between deficits in airway function and BHR in 
early life, genetic susceptibility and subsequent 
respiratory morbidity and lung function has been 
highlighted by longitudinal cohort studies [Turner 
et al. 2004; Le Souef, 2005; Bisgaard et al. 2012].
Prenatal risk factors for COPD
Irregularities during the susceptible period of foe-
tal lung development may render the adult lung 
less effective as a gas-exchanging unit and/or 
increase susceptibility to disease and the effects of 
ageing [Hooper and Wallace, 2006; Kallapur and 
Ikegami, 2006; Miller and Marty, 2010; Thornburg 
et al. 2010; Joss-Moore et al. 2011]. Differences in 
alveolar number due to early insults can influence 
the rate of disease progression, including accelerat-
ing rate of decline in FEV1 in patients with COPD 
[Massaro and Massaro, 2004].
Maternal smoking during pregnancy
While the incidence of maternal smoking during 
pregnancy has decreased during the past decade, 
it remains the single, most important, potentially 
preventable insult to the developing lung and a 
major cause of sudden infant death, LBW, pre-
term delivery and intrauterine growth restriction 
(IUGR) [Hayatbakhsh et al. 2009]. Experimental 
studies in various animal models have demon-
strated that in utero exposure to nicotine leads to 
smaller lungs with a reduced number of enlarged 
alveoli, alveolar changes suggestive of premature 
ageing and a low capillary density [Harding and 
Maritz, 2012]. There is evidence from animal 
models that prenatal exposure to nicotine causes 
abnormalities in airway branching and dimen-
sions and results in increased airway smooth 
muscle and collagen deposition, with subsequent 
reductions in airflow limitation, reduced FEV1 
and airway hyperreactivity [Sandberg et al. 2011; 
Wongtrakool et al. 2012].
Most evidence regarding postnatal effects of intra-
uterine smoke exposure in humans on subsequent 
lung function or respiratory morbidity has been 
derived from epidemiological and physiological 
studies [Stocks and Dezateux, 2003; Svanes et al. 
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2004; Moshammer et al. 2006; Palmer et al. 2006; 
Goksor et al. 2007; Haberg et al. 2007; Wang et al. 
2008; Hayatbakhsh et al. 2009; Wenten et al. 2009; 
Henderson et al. 2010; Hersoug et al. 2010; 
Schultz et al. 2010; Abbott and Winzer-Serhan, 
2012; Neuman et al. 2012]. Prenatal nicotine 
exposure may predispose to BHR during infancy, 
especially in those with a maternal history of 
asthma, with BHR still evident in early adulthood 
[Goksor et al. 2007]. Prenatal nicotine exposure is 
also associated with poor lung function at birth, 
which persists into early adulthood [Svanes et al. 
2004; Hayatbakhsh et al. 2009], regardless of 
postnatal exposure. Maternal smoking of 10 ciga-
rettes/day was found to increase risk of COPD in 
offspring by 1.7 (95% confidence interval, 1.2–
2.5) after adjustment for potential confounders. 
Within families, the effect of maternal smoking of 
10 cigarettes/day had the same effect on airflow 
limitation in the offspring as 10 years of personal 
smoking by the offspring [Upton et al. 2004].
Low Birth Weight (LBW)
Most epidemiological studies have shown that 
LBW is associated with increased cardiovascular 
and respiratory morbidity in later life. Factors 
responsible for LBW include both preterm deliv-
ery and IUGR. The commonest causes of IUGR, 
usually defined as birth weight less than tenth 
centile for gestational age, are impaired transpla-
cental supplies of oxygen and/or nutrients to the 
foetus, which are often associated with maternal 
smoking or pregnancy-induced hypertension 
[Pike et al. 2012; Narang and Bush, 2012]. 
Reductions in nutrients and oxygen supplies have 
wide-ranging effects on the developing lung, 
including diminished alveolar surface area, thick-
ened air–blood barriers and a reduction in lung 
weight. Animal models have indicated that these 
changes persist into adulthood [Karadag et al. 
2009; Pike et al. 2012].
IUGR has been identified as a risk factor for 
reduced lung function and respiratory morbidity 
during infancy [Hoo et al. 2004], childhood 
[Kotecha et al. 2010], and adulthood [Barker 
et al. 1991; Lawlor et al. 2005; Rona et al. 2005; 
Canoy et al. 2007], and has been shown to exac-
erbate the adverse impact of preterm delivery and 
postnatal hyperoxia. IUGR in the first and second 
trimester has been found to be associated with 
reduced vitamin E and abnormal lung function at 
5 years of age, together with increased risk of devel-
oping asthma [Turner et al. 2011]. The long-term 
impact of poor maternal nutrition during preg-
nancy in humans has also been shown by the 
increased prevalence of COPD amongst those 
born to mothers exposed to the Dutch famine 
(1944–1945) [Lopuhaa et al. 2000].
Associations have been reported between mater-
nal (prenatal) and postnatal dietary intake of 
fruit, fish or antioxidant vitamins and asthma 
[Fogarty and Britton, 2000], or COPD [Tabak 
et al. 2001]. Antioxidant vitamins may protect 
the lungs from oxidative damage by smoking or 
air pollution as shown in animal studies [Maritz 
and Rayise, 2011; Maritz et al. 2011]. Vitamin D 
is known to regulate multiplication of bronchial 
smooth muscle cells, which may be important in 
both asthma and COPD [Banerjee and Panettieri, 
2012]. Recent studies have attempted to deter-
mine whether maternal vitamin D supplementa-
tion can prevent the occurrence of chronic 
respiratory diseases [Weiss and Litonjua, 2011]. 
A number of studies have shown that maternal 
diets poor in vitamin D may lead to an increased 
risk of reactive airways in the offspring [Devereux 
et al. 2007; Erkkola et al. 2009; Miyake et al. 
2010; Camargo et al. 2011]. However, other 
studies have reported that higher serum 25(OH)
D concentrations during pregnancy may increase 
the risk of asthma in offspring by 9 years of age 
[Gale et al. 2008], and that children receiving 
supplemental vitamin D in the first year of life 
have a nonsignificant increased risk of developing 
asthma [Hypponen et al. 2004]. Current evi-
dence does not support routine vitamin D sup-
plementation during pregnancy.
Postnatal risk factors for COPD
Chronic lung disease of prematurity
Advances in prenatal and neonatal intensive 
care have led to marked improvements in sur-
vival rates for extremely preterm infants during 
recent years, but the prevalence of pulmonary 
sequelae in such infants has not declined 
[Moore et al. 2012; Costeloe et al. 2012]. 
Preterm delivery, that is, that occurring before 
37 weeks’ gestation, is the most common cause 
of abnormal lung development, and one with 
potentially life-long consequences. Although 
there are currently limited longitudinal studies 
beyond early adulthood, there is concern that 
such individuals face increased risk of develop-
ing COPD in later life [Silverman and Kuehni, 
2007; Bush, 2008].
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Infants born before 28 weeks’ gestation rarely 
survive without supplementary oxygen and venti-
latory assistance, the iatrogenic effects of which 
may compound the disruption of lung develop-
ment caused by preterm delivery per se. Exposure 
to hyperoxia, especially if combined with prenatal 
inflammation, results in the disruption of alveo-
lar development, reduced surface area for gas 
exchange, diffuse fibrosis and increased airway 
resistance in mice [Velten et al. 2010]. Even if pre-
term infants can be managed in room air at birth, 
this is relatively hyperoxic compared with the foe-
tal environment. Similarly, the switch from foetal 
to extrauterine breathing movements represents 
major changes in the mechanical forces imposed 
on the immature lung, which may adversely 
impact alveolar multiplication [Hooper and 
Wallace, 2006], elastin deposition and airway 
smooth muscle [Stocks and Hislop, 2002]. It is 
therefore hardly surprising that abnormal postna-
tal lung function and development have been 
reported even among preterm infants who require 
no ventilatory assistance at birth [Hoo et al. 2002; 
Friedrich et al. 2007; Colin et al. 2010].
Bronchopulmonary dysplasia (BPD) is com-
monly defined as continuing dependence on sup-
plemental oxygen at 36 weeks’ gestation in those 
born prematurely. BPD develops as the net result 
of pulmonary inflammation, oxidant stress and 
mechanical trauma to these extremely fragile and 
immature lungs, leading to disruption of normal 
alveolar and vascular development. Morphological 
studies in infants who died with BPD have reported 
substantial thickening of airway wall dimensions 
over the entire size range of airways, compatible 
with subsequent airflow obstruction in survivors 
[Tiddens et al. 2008]. Animal models suggest that 
hyperoxic insults to the immature lung may not 
only result in smooth muscle hyperplasia and air-
way remodelling [Choi et al. 2009], but reprogram-
ming of key innate immunoregulatory pathways in 
the lung [O’Reilly et al. 2008], thereby contributing 
to both reduced resistance to respiratory viral infec-
tions and the long-term risk of COPD.
In addition to increased risk of asthma and other 
respiratory morbidity, most longitudinal studies 
of lung function have reported evidence of persis-
tent airflow limitation (reduced FEV1 and FEV1/
FVC) and/or BHR during childhood, adolescence 
and adulthood in survivors of preterm birth 
[Vrijlandt et al. 2006; Baraldi and Filippone, 
2007; Baraldi et al. 2009; Doyle and Anderson, 
2010; Fawke et al. 2010; Kwinta and Pietrzyk, 
2010; Greenough, 2012; Hacking et al. 2012; 
Kotecha et al. 2012a, 2012b]. However, the male 
disadvantage with respect to reduced lung func-
tion and increased morbidity that is evident 
during infancy and childhood [Becklake and 
Kauffmann, 1999], appears to be reversed in 
adulthood [Vrijlandt et al. 2005; Postma, 2007]. 
Evidence of persistent respiratory symptoms and 
abnormal structure and lung function has been 
reported in young adults with BPD [Wong et al. 
2008]. The persistent reduction in airway func-
tion in those born preterm may be accompanied 
by an accelerated rate of decline of lung function 
[Doyle et al. 2006; Filippone et al. 2009]. Recent 
studies on young adult survivors of preterm birth 
have also revealed a worryingly high prevalence of 
current smoking (about 30% across various stud-
ies) [Doyle et al. 2006; Vrijlandt et al. 2006], 
which appears to further accelerate decline in lung 
function in this vulnerable population. Together, 
these findings suggest that young adult survivors 
of BPD may be left with residual functional and 
characteristic structural pulmonary abnormali-
ties, most notably emphysema.
Postnatal growth and nutrition
As alveolar numbers continue to increase after 
birth, postnatal nutrition and growth also affect 
the size of the adult lung. Studies show that chil-
dren who are breastfed have improved lung vol-
umes relative to those who are formula fed in 
early life [Ogbuanu et al. 2009; Dogaru et al. 
2012; Soto-Ramirez et al. 2012]. The impact of 
postnatal nutrition on lung development is espe-
cially pertinent in preterm infants, in whom nutri-
tion and growth are often impaired, contributing 
to reduced lung function and increased risk of 
respiratory morbidity in survivors during child-
hood and adolescence [Pike et al. 2012]. Vitamin 
A, D or E deficiency seems to have greatest effect 
on alveolar rather than airway development, with 
evidence that postnatal supplementation may 
potentially improve lung structure both in animal 
studies and humans [Checkley et al. 2010; Zosky 
et al. 2011; Esteban-Pretel et al. 2013]. While evi-
dence from observational studies suggests a role 
for diet in asthma and COPD, causality of the 
association is far less conclusive.
Postnatal exposure to environmental  
tobacco smoke
There are recognized difficulties in separating 
the effects of pre- and postnatal tobacco smoke 
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exposure, since virtually all women who smoke 
during pregnancy continue to do so after child 
birth [Le Souef, 2000; Stocks and Dezateux, 
2003]. Although current evidence suggests that 
smoking during pregnancy has the most detri-
mental effects on the developing lung, postnatal 
nicotine exposure has been shown to increase the 
risk of lower respiratory illness and reduced lung 
function in young children. Nevertheless, not all 
children who are exposed to pre- or postnatal 
tobacco smoke have diminished lung function or 
increased respiratory morbidity, reflecting, at 
least in part, differences in maternal and foetal 
genetic susceptibility [Tsai et al. 2008]. Several, 
though not all, studies have reported a protective 
effect of the infant and/or maternal GSTT1 non-
null genotype in children of smoking mothers, 
with respect to lung function, airway reactivity 
and respiratory morbidity [Gilliland et al. 2002; 
Murdzoska et al. 2010; Schultz et al. 2010].
Environmental pollution
The developing lung is highly susceptible to dam-
age from exposure to environmental pollutants 
[Miller and Marty, 2010; Soto-Martinez and Sly, 
2010]. The association between acute and chronic 
exposure to environmental pollutants and respira-
tory symptoms [Dales et al. 2009; da Silva et al. 
2012], as well as reduced lung function 
[Gauderman et al. 2007; Schindler et al. 2009; da 
Silva et al. 2012], is well described in both chil-
dren and adults. However, during the last decade, 
there has been growing interest in determining 
the impact of early life exposures to specific envi-
ronmental risk factors on the developing respira-
tory system. In addition to tobacco smoke, 
environmental pollutants relevant to respiratory 
tract illnesses include oxidant gases (ozone, nitro-
gen dioxide and oxygen), traffic-related emissions 
(carbon monoxide, nitrogen oxides and particu-
late matter [PM]), PM from biomass fuel com-
bustion (wood, dung or straw) and xenobiotics. 
Recent WHO reports estimate that up to 35% of 
those with COPD in low- and middle-income 
countries developed the disease after exposure to 
biomass fuel combustion [Lopez et al. 2006]. 
School children in rural India, where use of bio-
mass is common, also have significant reductions 
in lung function and increased incidence of 
asthma when compared with nonexposed peers 
[Padhi and Padhy, 2008].
Ambient ozone is formed by the action of sunlight 
on nitrogen oxides and reactive hydrocarbons, 
both of which are emitted by motor vehicles and 
industrial sources. Studies have demonstrated 
that foetal exposure to PM, ozone and carbon 
monoxide can lead to a host of developmental 
conditions including IUGR, LBW and preterm 
birth, with subsequent increased respiratory mor-
bidity. Exposure to traffic-related air pollution 
during infancy affects lung function in children 
up to 8 years of age, particularly in those sensi-
tized to common inhalant or food allergens 
[Schultz et al. 2012]. A direct link between child-
hood exposure to PM and increased vulnerability 
to adult respiratory disease is provided by studies 
showing an association between life-long biomass 
smoke exposure and development of COPD in 
noncigarette-smoking women [Grigg, 2009]. 
Experimental studies show that mice exposed 
to traffic-related PM, either pre- or postnatal, 
develop significant alterations of alveolar struc-
ture and lung elastic properties that adversely 
impact lung growth [Mauad et al. 2008]. Results 
from animal studies also implicate a number of 
xenobiotics (e.g. nitrofen, naphthalenes, arsenic, 
tetrachlorodibenzo-p-dioxin, di(2-ethylhexyl) 
phthalate) in adversely influencing lung matura-
tion and growth [Miller and Marty, 2010].
Childhood respiratory illnesses
The association between respiratory infections 
during childhood and chronic lung disease in later 
life has long been recognized. However, whether 
this is due to a viral infection in early life that affects 
the normal course of lung development making the 
individual susceptible to airway obstruction there-
after, or to pre- or perinatal insults to the develop-
ing lung that predispose the infant to early wheeze 
and subsequent airway obstruction has remained 
the subject of much debate. Until recently, inabil-
ity to measure routinely lung function in children 
below 6 years of age made it impossible to deter-
mine whether diminished lung function preceded 
early respiratory infections or vice versa, a situa-
tion that has now been overcome by advances in 
the field of infant and preschool lung function 
testing [Stocks and Lum, 2012]. While it has been 
reported that lower respiratory tract infections, 
especially those associated with respiratory syncy-
tial virus (RSV), are associated with abnormal 
lung function at follow up [Broughton et al. 2007], 
several studies have shown that children hospital-
ized as a result of RSV tend to have abnormal 
lung function before as well as after such infec-
tions [Turner et al. 2002; Drysdale et al. 2011]. 
Considerable evidence now exists that diminished 
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airway function, associated with a suboptimal 
intrauterine environment (e.g. maternal smoking, 
IUGR) may be present from birth and that such 
children are more likely to wheeze with subse-
quent viral infections [Pike et al. 2011, 2012; 
Narang and Bush, 2012]. In the follow up of the 
Tucson study at 22 years of age, those in the low-
est quartile for forced expiratory flows during the 
first year of life prior to any infections had the 
lowest lung function as adults [Stern et al. 2007].
Although lung function was not measured in the 
Dunedin cohort until school age, subsequent 
assessments demonstrated that lung function 
tracked between 9 years of age and 26 years of age, 
the lowest FEV1/FVC being observed in those 
with history of wheeze or asthma. Similarly, track-
ing of lung function has been clearly demonstrated 
in the Melbourne asthma cohort, with lower levels 
by 7 years of age in those with asthma (many of 
whom subsequently developed COPD) [Phelan 
et al. 2002; Tai et al. 2010]. A recent study sug-
gested that childhood disadvantages, which 
included the additive effect of maternal, paternal 
or childhood asthma, maternal history of smoking 
and childhood respiratory infections, were at least 
as great a risk for subsequent COPD as those 
related to active smoking in adults [Svanes et al. 
2010]. It has also been suggested that diagnosis 
of asthma as a child may confer a similar risk of 
developing COPD as an increase in age of 22 
years or 62 pack years of cigarette smoking 
[Shirtcliffe et al. 2012]. This functional evidence, 
combined with the structural changes observed in 
animal models described above, suggest that air-
way abnormalities are determined during foetal 
or early postnatal life and will increase the risk 
both of developing wheezing illnesses during 
childhood and COPD in later life.
Summary
Normal lung development is essential to attain 
maximum lung health in adulthood and minimize 
the risk of COPD. A better understanding of the 
long-term effects of early life factors on subse-
quent development of respiratory disease is 
imperative if appropriate preventive and manage-
ment strategies to reduce the burden of COPD 
are to be developed. Research in this field, how-
ever, is challenged by the need to separate the 
independent effects of genetic predisposition, 
preterm delivery, IUGR, neonatal respiratory dis-
orders and the impact of a wide range of treat-
ment strategies and early environmental insults, 
including childhood respiratory infections and 
environmental exposures. Adult chest physicians 
need to recognize the potential relevance of young 
adults presenting with airway obstruction and 
enquire about neonatal history including birth 
weight and preterm delivery. Investigations should 
then be directed at establishing the nature of the 
impairment and whether the airway obstruction is 
reversible in nature. It should be remembered 
that while reductions in airway calibre or increased 
airway wall compliance are usually responsible for 
symptoms of airway obstruction, reduced pulmo-
nary elastic recoil, such as may result from a dis-
ruption of alveolar development in early life, can 
also contribute to decreased airflows and hence 
the risk of developing emphysematous changes 
and COPD.
The onset of well-recognized but benign age-
related changes in lung function during early 
adulthood is of little consequence in health, due to 
the considerable lung reserves that are available. 
The outlook, however, is very different for those 
who fail to reach their full potential due to derange-
ments in lung development or those in whom the 
rate of lung decline is accelerated due to active 
smoking/environmental exposures or to structural 
and functional alterations present since birth. In 
such individuals, symptoms of COPD and associ-
ated restrictions on lifestyle are likely to develop 
once a critical threshold of lung function is reached. 
Since a reduced FEV1 in adult life carries with it a 
poor prognosis with respect not only to respiratory 
health but also to cardiovascular disease and over-
all mortality [Sin et al. 2005; Young et al. 2007], 
adult physicians need to recognize that lung dis-
ease is potentially associated with prematurity and 
other early life insults and offer long-term moni-
toring and advice to susceptible adults regarding 
the preservation of existing lung reserves. Where 
appropriate, such advice should include education 
regarding smoking cessation, physical activity lev-
els and maintaining a healthy diet [GOLD, 2011].
Conclusion
Given the evidence presented above it is no longer 
plausible to consider COPD as a disease of old 
age that is largely restricted to heavy smokers. 
Instead it has been shown that antenatal pro-
gramming, intra- and extrauterine environmental 
exposures and gene–environment interactions all 
play a major role in determining subsequent sus-
ceptibility to diseases such as COPD. As a result 
of such insults, some individuals are born with 
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low lung function, which then tracks through life, 
those with the lowest lung function as infants and 
young children tending to retain this state thereaf-
ter. With increasing survival of ever more imma-
ture infants, an increasing proportion of the 
population may be at risk of COPD in the future. 
If the continuing increase in incidence of COPD is 
to be reversed, it is essential to not only provide 
better education regarding diet, exercise and 
avoidance of smoking to preserve precious reserves 
of lung function, but to minimize risks to the 
developing lung by improvements in antenatal 
and neonatal care and reduction in pre- and post-
natal exposures to environmental pollutants.
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